Literature DB >> 31193675

Hypertensive heart disease associated with methamphetamine abuse.

Takatsugu Segawa1, Yoh Arita1, Nobuyuki Ogasawara1, Shinji Hasegawa1.   

Abstract

In Japan, methamphetamine accounts for the majority of illicit drug use and dependence is becoming a critical issue. Methamphetamine abuse induces cardiovascular complications, such as cardiomyopathy and heart failure. However, methamphetamine-associated cardiovascular complications are not common in Japan. We report the case of a young patient with hypertensive heart disease associated with habitual methamphetamine abuse. A 37-year-old man was admitted with congestive heart failure. He was a habitual methamphetamine abuser and developed chronic hypertension after he started methamphetamine abuse. His echocardiogram demonstrated left ventricular concentric hypertrophy with diffuse hypokinesis. An endomyocardial biopsy revealed histological evidence of a hypertensive heart. This case shows that habitual methamphetamine use may cause hypertensive heart disease because of chronic hypertension. <Learning objective: Methamphetamine-associated cardiomyopathy and congestive heart failure are uncommon in Japan. However, habitual methamphetamine abuse can be a potential cause of hypertensive heart disease due to chronic hypertension and congestive heart failure associated with hypertrophy.>.

Entities:  

Keywords:  Cardiomyopathy; Congestive heart failure; Hypertensive heart disease; Methamphetamine

Year:  2018        PMID: 31193675      PMCID: PMC6538565          DOI: 10.1016/j.jccase.2018.10.001

Source DB:  PubMed          Journal:  J Cardiol Cases        ISSN: 1878-5409


  10 in total

1.  Illicit stimulant use in a United States heart failure population presenting to the emergency department (from the Acute Decompensated Heart Failure National Registry Emergency Module).

Authors:  Deborah B Diercks; Gregg C Fonarow; J Douglas Kirk; Preeti Jois-Bilowich; Judd E Hollander; Jim Edward Weber; Janet Wynne; Roger M Mills; Clyde Yancy; W Franklin Peacock
Journal:  Am J Cardiol       Date:  2008-09-05       Impact factor: 2.778

2.  The association of methamphetamine use and cardiomyopathy in young patients.

Authors:  Khung-Keong Yeo; Mevan Wijetunga; Hiroki Ito; Jimmy T Efird; Kevin Tay; Todd B Seto; Kavitha Alimineti; Chieko Kimata; Irwin J Schatz
Journal:  Am J Med       Date:  2007-02       Impact factor: 4.965

Review 3.  A review of the role of electrocardiography in the diagnosis of left ventricular hypertrophy in hypertension.

Authors:  Giuseppe Schillaci; Francesca Battista; Giacomo Pucci
Journal:  J Electrocardiol       Date:  2012-09-28       Impact factor: 1.438

4.  Prevalence and nature of cardiovascular disease in methamphetamine-related death: A national study.

Authors:  Shane Darke; Johan Duflou; Sharlene Kaye
Journal:  Drug Alcohol Depend       Date:  2017-08-01       Impact factor: 4.492

5.  The unique histology of methamphetamine cardiomyopathy: a case report.

Authors:  Steven B Karch
Journal:  Forensic Sci Int       Date:  2011-06-12       Impact factor: 2.395

6.  Direct effects of methamphetamine on hypertrophy and microtubules in cultured adult rat ventricular myocytes.

Authors:  Y Maeno; M Iwasa; H Inoue; H Koyama; R Matoba; M Nagao
Journal:  Forensic Sci Int       Date:  2000-09-11       Impact factor: 2.395

Review 7.  Methamphetamine and cardiovascular pathology: a review of the evidence.

Authors:  Sharlene Kaye; Rebecca McKetin; Johan Duflou; Shane Darke
Journal:  Addiction       Date:  2007-06-12       Impact factor: 6.526

Review 8.  The Cardiac Complications of Methamphetamines.

Authors:  Elizabeth D Paratz; Neil J Cunningham; Andrew I MacIsaac
Journal:  Heart Lung Circ       Date:  2015-11-28       Impact factor: 2.975

9.  Methamphetamine-Associated Congestive Heart Failure: Increasing Prevalence and Relationship of Clinical Outcomes to Continued Use or Abstinence.

Authors:  Sean Sliman; Jill Waalen; David Shaw
Journal:  Cardiovasc Toxicol       Date:  2016-10       Impact factor: 3.231

10.  Cardiomyopathy associated with the smoking of crystal methamphetamine.

Authors:  R Hong; E Matsuyama; K Nur
Journal:  JAMA       Date:  1991-03-06       Impact factor: 56.272

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.